Skip to NavigationSkip to content

News

0
AstraZeneca have received some positive news on its hyperkalaemia drug, ZS-9, as it received a recommendation from the Committee for Medicinal...
0
It's been a big week with positive trial results in Crohn's, breast cancer and multiple sclerosis - check out the Top Ten most popular articles on...
0
The ABPI discusses how investing in R&D education and collaboration can reap long-term benefits to the pharmaceutical industry and the UK economy.
0
The National Pharmaceutical Pricing Authority (NPPA) has revealed that drugs from top pharma firms including AstraZeneca, Abbott, Cipla and Dr Reddy...

Features

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in...